Additionally, an advantage of our study is that bioinformatics was applied, which confirms that PPA1 expression is significantly higher in many tumor types, especially in lung cancer and ovarian cancer, and can regulate apoptosis and proliferation through TP53. This evidence concerns the gene TP53 and ovarian carcinoma.